Delivery Order SPE2DB20D1100-SPE2DB24FA8V1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,725.49 firm fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of September 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.86 firm-fixed-price delivery order is for the supply of 4561247098 - Cephalexin 250 mg/5 ml suspension, 200 ml, with a period of performance through June 15, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,419.07 firm fixed-price delivery order covers the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, with an ultimate completion date of August 16, 2023. The contract is not designated under a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,543.56 contract is for the delivery of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, to support military treatment facilities and other federal medical institutions. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $13,309.59 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of 4566614119 - Cephalexin 250 mg/5 ml suspension, 200 ml, a generic antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract, valued at $20,846.30, is a Firm Fixed Price Delivery Order with an ultimate completion date of September 19, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,302.02 delivery order is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml containers. The contract has a firm fixed price and an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,397.06 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract has an ultimate completion date of April 4, 2024 and was awarded on April 3, 2024 with no set-aside designation. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.83 Firm Fixed Price Delivery Order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of May 23, 2023 and was awarded on May 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,780.23, is for the delivery of Cephalexin 250 mg/5 ml suspension in 100 ml containers. This is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA8V1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and leading global pharmaceutical sourcing and distribution services company. The $10,230.71 fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, with a period of performance through March 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC, which did not have any set-aside designations. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply a wide range of medications, medical materials, and related distribution services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 3/22/24 |